본문바로가기

R&D

Research Performance

Humasis has been proving better
research results based on its innovative
technologies.

20
23
  • Development HIV raw materials for immunodiagnostic kit
  • Development Humasis COVID -19/Flu Ag Combo test (Ministry of Food and Drug Safety Authorization)
22
  • Developed 2022 COVID-19 NP Antigen
  • Humasis COVID -19 Ag N Test (permitted for export)
  • Humasis hs -Malaria P.f/Pan Antigen Test (permitted for export)
  • Developed Humasis COVID-19 RT-PCR Kit (certified by Ministry of Food and Drug Safety, CE)
  • Developed Humasis COVID-19 Variant RT-qPCR Kit (permitted by Ministry of Food and Drug Safety for export)
  • Developed Ministry of Food and Drug Safety (RUO)
21
  • Wellness R&D, Developed monitoring system
20
  • Developed HUBI-TAS (permitted by CE, Ministry of Food and Drug Safety)
  • Developed Novel Coronavirus (COVID-19) antigen test
19
  • Developed AI engine
18
  • Influenza/RSV Test Kit
  • High-Sensitivity HIV Antigen Test Kit
17
  • High-Sensitivity HCV Antigen Test Kit
  • Developed Quantitative Reagent for LH and FSH
  • Developed PCT Quantitative Test Reagent
16
  • High-Sensitivity Pregnancy Test Kit